OGT-719

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOGT-719
Drug Alias NameOGT-719
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionThymidylate synthase inhibitors
TargetsThymidylate synthase
Therapy Area/IndicationsColorectal NeoplasmsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOxford Glycosciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxford Glycosciences
Active IndicationsN/A
Inactive IndicationsColorectal NeoplasmsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A